LAMIACEAE (LABIATAE) Orthosiphon aristatus  (Blume) Miq.

 Synonym

  • LAMIACEAE (LABIATAE) Orthosiphon grandiflorus  Bold.
  • LAMIACEAE (LABIATAE) Orthosiphon stamineus  Benth.
 Thai / English name

  • หญ้าหนวดแมว*

[1-3] of 3 article(s) found

 หน้า  1  

[1] IN VITRO EFFECTS OF ACTIVE CONSTITUENTS AND EXTRACTS OF ORTHOSIPHON STAMINEUS ON THE ACTIVITIES OF THREE MAJOR HUMAN CDNA- EXPRESSED CYTOCHROME P450 ENZYMES.
PAN,YAN;ABD-RASHID,BADRUL AMINI;ISMAIL,ZAKIAH;ET AL.
CHEM BIOL INTERACT 2011 Vol.190(1),1-8  $38661 [Full]

Part Used : ทั้งต้น
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : Aqueous extract
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Negative
Remark : IC50 values for inhibition of CYP3A4 were 838.9 microgram/mL.
Note : - Orthosiphon stamineus (OS) components with IC50 values less than 100 microgram/mL (100 micromolar for active constituents) were subsequently determined for Ki (inhibition constant) values and inhibition modes. - In order to determine the modulatory effects of OS components on CYP activities, the enzyme assays were carried out in the presence and absence of OS extracts or active constituents. Metabolite (4-hydroxytolutamide, dextrophan and 6beta-hydroxytestosterone) formations were estimated using HPLC system. For each inhibition study, preliminary experiments were carried out by incubating a single enzyme specific substrate concentration around its Km with a range of OS extract and active constiuent concentrations to determine IC50 values (concentration on inhibitor causing 50% inhibition of enzyme activity).

Part Used : ทั้งต้น
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : methanol extract
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Negative
Remark : IC50 values for inhibition of CYP3A4 were 413.1 microgram/mL.
Note : - Orthosiphon stamineus (OS) components with IC50 values less than 100 microgram/mL (100 micromolar for active constituents) were subsequently determined for Ki (inhibition constant) values and inhibition modes. - In order to determine the modulatory effects of OS components on CYP activities, the enzyme assays were carried out in the presence and absence of OS extracts or active constituents. Metabolite (4-hydroxytolutamide, dextrophan and 6beta-hydroxytestosterone) formations were estimated using HPLC system. For each inhibition study, preliminary experiments were carried out by incubating a single enzyme specific substrate concentration around its Km with a range of OS extract and active constiuent concentrations to determine IC50 values (concentration on inhibitor causing 50% inhibition of enzyme activity).

Part Used : ทั้งต้น
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : dichloromethane extract
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : CYP3A4 was moderately inhibited by OS dichloromethane extract in mixed-type mode with an IC50 value of 96.5 and a Ki value of 93.7 microgram/mL.
Note : - Orthosiphon stamineus (OS) components with IC50 values less than 100 microgram/mL (100 micromolar for active constituents) were subsequently determined for Ki (inhibition constant) values and inhibition modes. - In order to determine the modulatory effects of OS components on CYP activities, the enzyme assays were carried out in the presence and absence of OS extracts or active constituents. Metabolite (4-hydroxytolutamide, dextrophan and 6beta-hydroxytestosterone) formations were estimated using HPLC system. For each inhibition study, preliminary experiments were carried out by incubating a single enzyme specific substrate concentration around its Km with a range of OS extract and active constiuent concentrations to determine IC50 values (concentration on inhibitor causing 50% inhibition of enzyme activity).

Part Used : ทั้งต้น
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : Petroleum ether extract
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : CYP3A4 was found to be noncompetitively inhibited by OS petroleum ether extract with IC50 value of 46.3 and Ki value of 44.9 microgram/mL.
Note : - Orthosiphon stamineus (OS) components with IC50 values less than 100 microgram/mL (100 micromolar for active constituents) were subsequently determined for Ki (inhibition constant) values and inhibition modes. - In order to determine the modulatory effects of OS components on CYP activities, the enzyme assays were carried out in the presence and absence of OS extracts or active constituents. Metabolite (4-hydroxytolutamide, dextrophan and 6beta-hydroxytestosterone) formations were estimated using HPLC system. For each inhibition study, preliminary experiments were carried out by incubating a single enzyme specific substrate concentration around its Km with a range of OS extract and active constiuent concentrations to determine IC50 values (concentration on inhibitor causing 50% inhibition of enzyme activity).

Part Used : ทั้งต้น
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : Rosmarinic acid
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : CYP3A4 was moderate inhibited by rosmarinic acid in uncompetitive inhibition mode with an IC50 value of 86.9 microgram/mL (241.2 micromolar) and a Ki of 118.3 microgram/mL (328.3 micromolar).
Note : - Orthosiphon stamineus (OS) components with IC50 values less than 100 microgram/mL (100 micromolar for active constituents) were subsequently determined for Ki (inhibition constant) values and inhibition modes. - In order to determine the modulatory effects of OS components on CYP activities, the enzyme assays were carried out in the presence and absence of OS extracts or active constituents. Metabolite (4-hydroxytolutamide, dextrophan and 6beta-hydroxytestosterone) formations were estimated using HPLC system. For each inhibition study, preliminary experiments were carried out by incubating a single enzyme specific substrate concentration around its Km with a range of OS extract and active constiuent concentrations to determine IC50 values (concentration on inhibitor causing 50% inhibition of enzyme activity).

Part Used : ทั้งต้น
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : sinensetin
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Negative
Remark : IC50 values for inhibition of CYP3A4 were >200 microgram/mL (>537.1 micromolar).
Note : - Orthosiphon stamineus (OS) components with IC50 values less than 100 microgram/mL (100 micromolar for active constituents) were subsequently determined for Ki (inhibition constant) values and inhibition modes. - In order to determine the modulatory effects of OS components on CYP activities, the enzyme assays were carried out in the presence and absence of OS extracts or active constituents. Metabolite (4-hydroxytolutamide, dextrophan and 6beta-hydroxytestosterone) formations were estimated using HPLC system. For each inhibition study, preliminary experiments were carried out by incubating a single enzyme specific substrate concentration around its Km with a range of OS extract and active constiuent concentrations to determine IC50 values (concentration on inhibitor causing 50% inhibition of enzyme activity).

Part Used : ทั้งต้น
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : eupatorin
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : CYP3A4 was found to be noncompetitively inhibited by OS petroleum ether extract with IC50 value of 5.0 microgram/mL (14.5 micromolar) and Ki value of 3.2 microgram/mL (9.3 micromolar).
Note : - Orthosiphon stamineus (OS) components with IC50 values less than 100 microgram/mL (100 micromolar for active constituents) were subsequently determined for Ki (inhibition constant) values and inhibition modes. - In order to determine the modulatory effects of OS components on CYP activities, the enzyme assays were carried out in the presence and absence of OS extracts or active constituents. Metabolite (4-hydroxytolutamide, dextrophan and 6beta-hydroxytestosterone) formations were estimated using HPLC system. For each inhibition study, preliminary experiments were carried out by incubating a single enzyme specific substrate concentration around its Km with a range of OS extract and active constiuent concentrations to determine IC50 values (concentration on inhibitor causing 50% inhibition of enzyme activity).

[2] การใช้สมุนไพรและผลิตภัณฑ์เสริมอาหารที่มีโอกาสเกิดอันตรกิริยากับยาที่ใช้ในผู้ป่วยโรคเรื้อรัง
ชุลีกร สอนสุวิทย์, ชบาไพร โพธิ์สุยะ, ดวงกมล จรูญวนิชกุล และคณะ
วารสารไทยเภสัชศาสตร์และวิทยาการสุขภาพ 2012 Vol.7(4),149-54  $46679 [Full]

Part Used : ไม่ระบุ
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : -
Type of experiment : human
Type of animal : -
Type of study : Cross-section
N(Total) : 56 (M/F = 24/32)
N(Treatment) : 1
Sex : Both sex
Age : 68.7 +/- 7.7 yrs
Route : Oral administration
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : Amlodipine*/Amlopine
Dose/Conc.(drug) : -
Result : Positive
Remark : หญ้าหนวดแมวมีฤทธิ์ยับยั้งเอนไซม์ CYP3A4 ทำให้ยาเมตาบอไลซ์ผ่าน CYP3A4 ถูกแปรสภาพลดลง ทำให้ระดับยาในเลือดสูงขึ้น
Note : Data incomplete, data from review article

[3] P02 INHIBITORY EFFECT AND MECHANISM-BASED INHIBITION OF THAI HERBAL PLANTS ON CYP3A4 AND CYP2D6 ACTIVITIES.
DUMRONGSAKUNCHAI W,ATTAKORNVATTANA V,SOMANABANDHU A,ET AL.
THAI J PHARMACOL 2007 Vol.29(1),35-9  416780 [Abstract]

Part Used : ไม่ระบุ
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : ethanol
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : The ethanolic extract of Orthosiphon aristatus inhibited CYP3A4 activity with IC50 value 40+/-8.7 microgram/ml.
Note : Testosterone 6beta-hydroxylase and dextromethorphan O-demethylase were used as maker of CYP3A4 and CYP2D6 activity, respectively.

Part Used : ไม่ระบุ
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : aqueous
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : The aqueous extract of Orthosiphon aristatus inhibited CYP3A4 activity with IC50 value 286.7+/-65.1 microgram/ml.
Note : Testosterone 6beta-hydroxylase and dextromethorphan O-demethylase were used as maker of CYP3A4 and CYP2D6 activity, respectively.


 หน้า  1